Questions about exercise and nutrition during GLP-1 treatment.

Planning exercise while taking prescribed GLP-1 medication

Reduced appetite, gastrointestinal symptoms and changes in food intake can affect how you feel during exercise. The manufacturer's US Mounjaro prescribing information describes gastrointestinal adverse reactions and other precautions. Your UAE prescriber and the information supplied with your medication are the relevant sources for your treatment.

Questions for your prescribing clinician

• Are there restrictions on exercise intensity or activities given my health history and other medicines?
• What symptoms mean I should stop exercising and seek medical advice?
• Do I need individual guidance on nutrition, fluids or blood glucose around exercise?
• What should I review if a medication change affects my ability to eat, recover or train?

Questions for your coach

• How will the programme reflect my clinician's restrictions and current ability?
• How will you record exercise tolerance and adjust the session if I feel unwell?
• Which progress measures will we use besides weight?

Discuss resistance exercise, everyday activity and recovery as parts of the overall plan. The research below has specific populations and does not prove that one weekly routine suits every GLP-1 user. Medication timing and dose changes belong with the prescriber.

Preventing muscle loss on GLP-1: the core risk explained

This is the most important thing to understand about GLP-1 medications and fitness: these drugs do not selectively target fat. They create a significant calorie deficit through appetite suppression, and the body will draw on both fat stores and lean muscle to fuel itself in that deficit.

A 160-participant DXA substudy of SURMOUNT-1 found that tirzepatide reduced both fat mass and lean mass in adults with obesity or overweight. Lean mass is not identical to skeletal muscle, and this study did not test a specific strength-training programme.¹ This matters for several reasons:

• Metabolic rate: Muscle is metabolically active tissue. Losing muscle reduces resting energy expenditure, making weight maintenance harder after stopping medication.
• Functional strength: Particularly relevant for adults over 40, where muscle loss (sarcopenia) has compounding effects on mobility, bone density, and injury risk.
• Body composition: A person who loses 15 kg but loses a significant portion as muscle ends up with a higher body fat percentage relative to bodyweight than they would with muscle-preserving strategies — even at the lower weight.

The two levers: resistance training and protein

A systematic review found that resistance training helped preserve lean mass during calorie restriction in older adults with obesity.² That review did not test GLP-1 treatment and does not establish the same effect for every patient. Ask your prescribing clinician and an appropriately qualified exercise professional how the findings apply to your situation.

Body composition tracking: measuring what matters

Scale weight alone is a poor indicator of success during GLP-1 therapy. A person who gains 1 kg of muscle and loses 3 kg of fat has dramatically improved their health and body composition — but the scale only shows minus 2 kg, which can feel discouraging.

More useful tracking methods include:

• DEXA scan: One method of estimating body composition — separates fat mass, lean mass, and bone density. Available at a number of medical and sports medicine clinics in Dubai. A clinician can advise whether a scan is useful and when to repeat it.
• InBody or BIA (bioelectrical impedance) scan: Less precise than DEXA but widely available at gyms, clinics, and some pharmacies in Dubai. Useful for tracking trends over time.
• Strength and performance markers: If you are maintaining or improving on key compound lifts (squats, deadlifts, rows) while losing weight, muscle preservation is likely occurring.
• Progress photos and measurements: Circumference measurements at the waist, hips, and thighs combined with photos provide visible evidence of body composition change that the scale misses.

PTD Fitness tracks body composition — not just scale weight — with every client. Discuss appropriate tracking methods and frequency with your prescribing doctor and trainer.

Can you build muscle on a GLP-1? Yes — here is what the programme looks like

A common misconception is that GLP-1 medications are purely a fat-loss tool and that muscle building must wait until after the medication phase. This is not necessarily accurate. Body recomposition — gaining muscle while losing fat — is well-documented in several contexts:

• Individuals new to resistance training (sometimes called "beginner gains")
• Individuals returning to training after a break of 6+ months (muscle memory effect)
• Individuals with a high baseline body fat percentage, where more energy is available from fat oxidation even in a calorie deficit

All three categories are common among people starting GLP-1 therapy. The key enabling conditions are the same as in any recomposition context: sufficient training stimulus and sufficient protein.

What a muscle-building programme on GLP-1 looks like

Core programming elements for muscle gain or recomposition on GLP-1:

• Progressive overload: Systematically increase resistance, volume, or both over time. Without this principle, the training stimulus is insufficient to drive muscle adaptation.
• Compound movements first: Squats, deadlifts, hip thrusts, rows, bench press, and overhead press engage multiple muscle groups and produce the greatest anabolic hormonal response.
• 3–4 resistance sessions per week: Enough to provide adequate stimulus and allow recovery within the reduced-energy context.
• Protein timing: Distributing protein intake across 3–4 meals (rather than 1–2) maximises muscle protein synthesis throughout the day. Each meal should contain a meaningful protein component — not just the largest meal of the day.
• Recovery priority: Sleep quality and quantity directly affect muscle recovery and hormone balance. 7–9 hours per night is the general evidence-based recommendation.

Protein targets on Mounjaro when appetite is suppressed — how to actually hit them

Protein is the single most important dietary variable for muscle preservation on GLP-1 therapy. Yet GLP-1 medications make hitting protein targets harder by design — appetite suppression means smaller meals, fewer eating occasions, and less overall food intake.

Calculating your personal protein target

Table context: The numbers above illustrate weight multiplied by the displayed ranges; they are not personalised targets for GLP-1 treatment. Ask a registered dietitian or your prescriber about your needs.

Note: when using lean body mass (total weight minus estimated fat mass) rather than total bodyweight as the denominator, higher g/kg targets are often recommended — this is more relevant for individuals at higher body fat percentages. A PTD Fitness coach or registered dietitian can help calculate the right target for your context.

High-protein foods available in Dubai — halal and practical

Practical strategies to hit protein targets when appetite is low

• Protein first, every meal: On days when you may only eat half your plate, ensure the protein portion is eaten first. The rest is secondary.
• 4 smaller protein occasions vs 2 large meals: Distributes the target across more eating windows, and smaller portions are easier to manage with GLP-1 nausea.
• Front-load the day: Appetite tends to be stronger in the morning and early afternoon for many GLP-1 users. Put your largest protein serving in this window.
• Liquid protein on low days: A halal-certified protein shake or Greek yoghurt smoothie can meet a significant portion of daily protein when solid food is not appealing.
• Track for accountability: Even rough tracking (noting approximate grams per meal) raises awareness of gaps. A PTD Fitness coach can review your food log and make targeted adjustments.

Symptoms, recovery and training timing

Tell your coach if you feel unwell or cannot eat and drink normally. Seek medical advice for persistent or concerning symptoms and follow the urgent-care advice supplied with your medicine. Avoid treating a change in exercise performance as something to push through automatically.

A brief log of symptoms, food intake, activity and recovery can help your clinician assess what needs to change. The coach can adjust the exercise plan within clinical guidance; they should not change the medication dose or injection schedule.

Weight regain after stopping Mounjaro — how training reduces the risk

GLP-1 medications work partly through their ongoing pharmacological action — when the drug is discontinued, the appetite-suppressing effect diminishes and hunger patterns can return to pre-medication levels or higher. Research following participants after stopping GLP-1 drugs has found that body weight tends to return toward baseline without continued lifestyle intervention.

This is not a failure of the individual — it reflects the biological reality that the conditions driving weight gain (genetics, hormonal set points, environment, behaviours) persist after medication stops. The goal of lifestyle intervention during the medication phase is to shift as many of those conditions as possible in a sustainable direction.

The muscle argument: why it matters for post-medication maintenance

Muscle tissue is one of the body's primary consumers of energy at rest. For every kilogram of lean mass maintained or added during the GLP-1 phase:

• Resting energy expenditure (the calories burned at rest) is higher
• Insulin sensitivity is improved, which affects fat storage and appetite regulation
• Physical capacity (strength, mobility, endurance) is preserved or improved, making continued activity easier

This is the evidence-based case for why building a consistent resistance training habit and adequate protein intake during GLP-1 therapy — regardless of medication duration — is the most protective strategy available. The habits and muscle built during the medication phase do not disappear when the medication does.

Building a post-medication maintenance plan

An effective transition plan, built in coordination with your prescribing doctor and a qualified trainer, typically addresses:

1. Continuing resistance training: The training habit established during GLP-1 therapy should continue — this is the single most important lifestyle carry-over
2. Recalibrating protein targets: As appetite normalises post-medication, intentional protein targets remain important even if easier to hit
3. Body composition monitoring: Track composition changes in the months after stopping — early drift toward fat regain can be addressed before becoming significant
4. Gradual caloric adjustment: Appetite will increase; a structured nutritional framework prevents rapid increase in caloric intake above maintenance

PTD Fitness coaches help clients build exactly this kind of sustainable, post-medication maintenance plan — it is a core component of the GLP-1 protocol.

Women over 40 and menopause on GLP-1 — additional considerations

For women over 40, particularly those in perimenopause or post-menopause, GLP-1 therapy intersects with a set of additional physiological changes that affect both muscle preservation and training response:

• Accelerated muscle loss: The decline in oestrogen during menopause accelerates age-related muscle loss (sarcopenia). GLP-1-induced calorie restriction, if not managed with resistance training and protein, can compound this effect significantly.
• Bone density: Oestrogen also plays a protective role in bone density. Rapid weight loss — regardless of mechanism — can reduce bone mineral density. Weight-bearing resistance exercise is one of the most effective countermeasures and should be a central component of any programme for this demographic.
• Body composition distribution: Post-menopausal hormonal changes shift fat distribution toward central/visceral fat. GLP-1 medications are effective at reducing visceral fat, but resistance training is specifically important for preserving the lean mass that counteracts this shift.
• Recovery and sleep: Menopause-related sleep disruption can compound GLP-1 fatigue. Good sleep hygiene and managing training load with recovery in mind are especially important.

PTD Fitness has coaches experienced in programming for women over 40, including those on GLP-1 therapy. A free consultation will identify the right coach for your specific context.

Personal trainer for GLP-1 users in Dubai — PTD Fitness's coordinated approach

The question "do I need a personal trainer on Mounjaro?" is worth addressing directly. GLP-1 medications are highly effective at driving a calorie deficit. The training and nutrition decisions made within that deficit determine whether the outcome is fat loss with muscle preservation, or fat loss with significant muscle loss alongside it.

A qualified trainer with GLP-1 protocol experience provides:

• A resistance programme designed specifically for the energy constraints of GLP-1 therapy — not a standard programme that ignores reduced training capacity
• Ongoing adaptation of the programme through dose escalation, side effect peaks, and stable-dose phases
• Accountability for protein targets, sleep, and recovery — the factors that matter most but are easiest to let slip during a period of appetite suppression
• Body composition tracking that separates fat loss from muscle loss, so you know what is actually happening
• Coordination with the medical team — passing relevant notes to the prescribing physician and flagging exercise-related concerns

PTD Fitness's GLP-1 protocol: what is included

PTD Fitness's dedicated GLP-1 training protocol covers all of the above. Sessions are 1-on-1 and in-home across Dubai and Abu Dhabi. The protocol is designed to coordinate with — not compete with — the prescribing physician's plan. PTD coaches are fitness professionals; all medical decisions remain with the client's doctor.

Mounjaro availability and price in Dubai — informational only

For informational context: Mounjaro (tirzepatide) and semaglutide-based medications (Ozempic, Wegovy) are available in the UAE by prescription from licensed physicians, including endocrinologists, obesity medicine specialists, and GPs with relevant training.

Several specialist clinics in Dubai offer obesity medicine programmes that may include GLP-1 prescriptions as part of a broader supervised plan. Reported price ranges cited publicly in UAE media have varied widely depending on dose and clinic — current, accurate pricing should be confirmed directly with the prescribing clinic, not from third-party sources.

If you are considering GLP-1 medication and want a starting point, consult your GP or request a referral to an endocrinologist or obesity medicine specialist in Dubai. Prescription eligibility typically involves BMI assessment, health history review, and monitoring requirements.

Continue exploring